0001746139-25-000003.txt : 20251223 0001746139-25-000003.hdr.sgml : 20251223 20251223102458 ACCESSION NUMBER: 0001746139-25-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251223 DATE AS OF CHANGE: 20251223 EFFECTIVENESS DATE: 20251223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Auron Therapeutics, Inc. CENTRAL INDEX KEY: 0001746139 ORGANIZATION NAME: EIN: 823865673 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-533785 FILM NUMBER: 251595837 BUSINESS ADDRESS: STREET 1: 55 CHAPEL STREET STREET 2: SUITE 100 CITY: NEWTON STATE: MA BUSINESS PHONE: 310-922-5881 MAIL ADDRESS: STREET 1: 55 CHAPEL STREET STREET 2: SUITE 100 CITY: NEWTON STATE: MA D/A 1 primary_doc.xml X0708 D/A LIVE 0001746139 Auron Therapeutics, Inc. 55 CHAPEL STREET SUITE 100 NEWTON MA MASSACHUSETTS 02458 310-922-5881 DELAWARE None None Corporation true Katharine Yen 55 Chapel Street Suite 100 Newton MA MASSACHUSETTS 02458 Executive Officer Director Alexandra Cantley 55 Chapel Street Suite 100 Newton MA MASSACHUSETTS 02458 Director Briggs Duncan Morrison 55 Chapel Street Suite 100 Newton MA MASSACHUSETTS 02458 Director Anna French 55 Chapel Street Suite 100 Newton MA MASSACHUSETTS 02458 Director Pini Orbach 55 Chapel Street Suite 100 Newton MA MASSACHUSETTS 02458 Director Serge Messerlian 55 Chapel Street Suite 100 Newton MA MASSACHUSETTS 02458 Director Victoria Richon 55 Chapel Street Suite 100 Newton MA MASSACHUSETTS 02458 Director Biotechnology Decline to Disclose 06b true 0001746139-24-000003 2024-12-18 true true false 0 42289180 27289180 15000000 false 16 0 0 0 false Auron Therapeutics, Inc. /s/ Katharine Yen Katharine Yen Chief Executive Officer 2025-12-23